EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): A$0.22

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is A$0.21. In 2024 the company made an earnings per share (EPS) of A$0.19 an increase over its 2023 EPS that were of A$0.13.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	A$0.22
2024	A$0.19	42.43%
2023	A$0.13	8.77%
2022	A$0.12	-20.62%
2021	A$0.16	-26.59%
2020	A$0.21	27.24%
2019	A$0.17	28.41%
2018	A$0.13	20.04%
2017	A$0.11	31.21%
2016	A$0.08273	11.46%
2015	A$0.07422	36.27%
2014	A$0.05447	19.77%
2013	A$0.04547	18.05%
2012	A$0.03852	23.9%
2011	A$0.03109	26.9%
2010	A$0.02450	12.37%
2009	A$0.02180	56.6%
2008	A$0.01392	9.18%
2007	A$0.01275	114.48%
2006	A$0.005946	64.83%
2005	A$0.003607	35.55%
2004	A$0.002661	29.73%
2003	A$0.002051	19.86%
2002	A$0.001712	-2.71%
2001	A$0.001759	1.02%
2000	A$0.001741

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions